Role of Imaging in the Diagnosis of Large and Medium-Sized Vessel Vasculitis

Rheumatic Disease Clinics of North America

Volumn 39, Issue 3, 2013, Pages 593-608

  Pipitone, Nicolò ^a   Versari, Annibale ^a   Hunder, Gene G ^b   Salvarani, Carlo ^a  

^a S MARIA NUOVA HOSPITAL   (Italy)

^b Mayo Clinic   (United States)

Author keywords

Magnetic resonance imaging; Positron emission tomography; Tomography radiograph computed; Ultrasonography; Vasculitis

Indexed keywords

ADAMANTIADES BEHCET DISEASE; ANGIOGRAPHY; BEHCET DISEASE; BLOOD VESSEL WALL; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIGITAL SUBTRACTION ANGIOGRAPHY; ECHOGRAPHY; HUMAN; INTERMETHOD COMPARISON; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; TEMPORAL ARTERY; VASCULITIS; WEGENER GRANULOMATOSIS;

HUMANS; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER, COLOR; VASCULITIS;

EID: 84878116867     PISSN: 0889857X     EISSN: 15583163     Source Type: Journal    
DOI: 10.1016/j.rdc.2013.02.002     Document Type: Review

References (94)

1. Scott D.G., Watts R.A. Classification and epidemiology of systemic vasculitis. Br J Rheumatol 1994, 33:897-899.
2. Grayson P.C., Maksimowicz-McKinnon K., Clark T.M., et al. Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis. Ann Rheum Dis 2012, 71:1329-1334.
3. Pipitone N., Versari A., Salvarani C. Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update. Rheumatology (Oxford) 2008, 47:403-408.
4. Schmidt W.A., Kraft H.E., Vorpahl K., et al. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 1997, 337:1336-1342.
5. Ball E.L., Walsh S.R., Tang T.Y., et al. Role of ultrasonography in the diagnosis of temporal arteritis. Br J Surg 2010, 97:1765-1771.
6. Arida A., Kyprianou M., Kanakis M., et al. The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: a second meta-analysis. BMC Musculoskelet Disord 2010, 11:44.
7. Schmidt W.A., Krause A., Schicke B., et al. Do temporal artery duplex ultrasound findings correlate with ophthalmic complications in giant cell arteritis?. Rheumatology (Oxford) 2009, 48:383-385.
8. Schmidt W.A., Natusch A., Moller D.E., et al. Involvement of peripheral arteries in giant cell arteritis: a color Doppler sonography study. Clin Exp Rheumatol 2002, 20:309-318.
9. Aschwanden M., Kesten F., Stern M., et al. Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2x11 arterial regions. Ann Rheum Dis 2010, 69:1356-1359.
10. Ghinoi A., Pipitone N., Nicolini A., et al. Large-vessel involvement in recent-onset giant cell arteritis: a case-control colour-Doppler sonography study. Rheumatology (Oxford) 2012, 51:730-734.
11. Schmidt W.A., Seifert A., Gromnica-Ihle E., et al. Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology (Oxford) 2008, 47:96-101.
12. Bossert M., Prati C., Balblanc J.C., et al. Aortic involvement in giant cell arteritis: current data. Joint Bone Spine 2011, 78:246-251.
13. Maeda H., Handa N., Matsumoto M., et al. Carotid lesions detected by B-mode ultrasonography in Takayasu's arteritis: " macaroni sign" as an indicator of the disease. Ultrasound Med Biol 1991, 17:695-701.
14. Nicoletti G., Mannarella C., Nigro A., et al. The " macaroni sign" of Takayasu's arteritis. J Rheumatol 2009, 36:2042-2043.
15. Taniguchi N., Itoh K., Honda M., et al. Comparative ultrasonographic and angiographic study of carotid arterial lesions in Takayasu's arteritis. Angiology 1997, 48:9-20.
16. Giordana P., Baque-Juston M.C., Jeandel P.Y., et al. Contrast-enhanced ultrasound of carotid artery wall in Takayasu disease: first evidence of application in diagnosis and monitoring of response to treatment. Circulation 2011, 124:245-247.
17. Magnoni M., Dagna L., Coli S., et al. Assessment of Takayasu arteritis activity by carotid contrast-enhanced ultrasound. Circ Cardiovasc Imaging 2011, 4:e1-e2.
18. De Miguel M.E., Roxo A., Castillo C., et al. The utility and sensitivity of colour Doppler ultrasound in monitoring changes in giant cell arteritis. Clin Exp Rheumatol 2012, 30:S34-S38.
19. Schmidt W.A., Nerenheim A., Seipelt E., et al. Diagnosis of early Takayasu arteritis with sonography. Rheumatology (Oxford) 2002, 41:496-502.
20. Hauenstein C., Reinhard M., Geiger J., et al. Effects of early corticosteroid treatment on magnetic resonance imaging and ultrasonography findings in giant cell arteritis. Rheumatology (Oxford) 2012, 51:1999-2003.
21. Kissin E.Y., Merkel P.A. Diagnostic imaging in Takayasu arteritis. Curr Opin Rheumatol 2004, 16:31-37.
22. De M.E., Castillo C., Rodriguez A., et al. Learning and reliability of colour Doppler ultrasound in giant cell arteritis. Clin Exp Rheumatol 2009, 27:S53-S58.
23. Gotway M.B., Araoz P.A., Macedo T.A., et al. Imaging findings in Takayasu's arteritis. AJR Am J Roentgenol 2005, 184:1945-1950.
24. Yoshida S., Akiba H., Tamakawa M., et al. The spectrum of findings in supra-aortic Takayasu's arteritis as seen on spiral CT angiography and digital subtraction angiography. Cardiovasc Intervent Radiol 2001, 24:117-121.
25. Chung J.W., Kim H.C., Choi Y.H., et al. Patterns of aortic involvement in Takayasu arteritis and its clinical implications: evaluation with spiral computed tomography angiography. J Vasc Surg 2007, 45:906-914.
26. Paul J.F., Fiessinger J.N., Sapoval M., et al. Follow-up electron beam CT for the management of early phase Takayasu arteritis. J Comput Assist Tomogr 2001, 25:924-931.
27. Yamada I., Nakagawa T., Himeno Y., et al. Takayasu arteritis: evaluation of the thoracic aorta with CT angiography. Radiology 1998, 209:103-109.
28. Prieto-Gonzalez S., Arguis P., Garcia-Martinez A., et al. Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography. Ann Rheum Dis 2012, 71:1170-1176.
29. Choe Y.H., Kim D.K., Koh E.M., et al. Takayasu arteritis: diagnosis with MR imaging and MR angiography in acute and chronic active stages. J Magn Reson Imaging 1999, 10:751-757.
30. Choe Y.H., Lee W.R. Magnetic resonance imaging diagnosis of Takayasu arteritis. Int J Cardiol 1998, 66(Suppl 1):S175-S179.
31. Geiger J., Bley T., Uhl M., et al. Diagnostic value of T2-weighted imaging for the detection of superficial cranial artery inflammation in giant cell arteritis. J Magn Reson Imaging 2010, 31:470-474.
32. Ghinoi A., Zuccoli G., Nicolini A., et al. 1T magnetic resonance imaging in the diagnosis of giant cell arteritis: comparison with ultrasonography and physical examination of temporal arteries. Clin Exp Rheumatol 2008, 26:S76-S80.
33. Bley T.A., Uhl M., Carew J., et al. Diagnostic value of high-resolution MR imaging in giant cell arteritis. AJNR Am J Neuroradiol 2007, 28:1722-1727.
34. Brack A., Martinez-Taboada V., Stanson A., et al. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 1999, 42:311-317.
35. Angeli E., Vanzulli A., Venturini M., et al. The role of radiology in the diagnosis and management of Takayasu's arteritis. J Nephrol 2001, 14:514-524.
36. Garg S.K., Mohan S., Kumar S. Diagnostic value of 3D contrast-enhanced magnetic resonance angiography in Takayasu's arteritis-a comparative study with digital subtraction angiography. Eur Radiol 2011, 21:1658-1666.
37. Tso E., Flamm S.D., White R.D., et al. Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum 2002, 46:1634-1642.
38. Bley T.A., Markl M., Schelp M., et al. Mural inflammatory hyperenhancement in MRI of giant cell (temporal) arteritis resolves under corticosteroid treatment. Rheumatology (Oxford) 2008, 47:65-67.
39. Bley T.A., Ness T., Warnatz K., et al. Influence of corticosteroid treatment on MRI findings in giant cell arteritis. Clin Rheumatol 2007, 26:1541-1543.
40. Ahdab R., Thabuy F., Menager de F.E., et al. Reversible vertebral artery stenosis following corticotherapy in giant cell arteritis. Eur Neurol 2008, 59:331.
41. Willinsky R.A., Taylor S.M., TerBrugge K., et al. Neurologic complications of cerebral angiography: prospective analysis of 2,899 procedures and review of the literature. Radiology 2003, 227:522-528.
42. Meller J., Strutz F., Siefker U., et al. Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging 2003, 30:730-736.
43. Belhocine T., Blockmans D., Hustinx R., et al. Imaging of large vessel vasculitis with (18)FDG PET: illusion or reality? A critical review of the literature data. Eur J Nucl Med Mol Imaging 2003, 30:1305-1313.
44. Hautzel H., Sander O., Heinzel A., et al. Assessment of large-vessel involvement in giant cell arteritis with 18F-FDG PET: introducing an ROC-analysis-based cutoff ratio. J Nucl Med 2008, 49:1107-1113.
45. Besson F.L., Parienti J.J., Bienvenu B., et al. Diagnostic performance of (1)(8)F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 2011, 38:1764-1772.
46. Meller J., Grabbe E., Becker W., et al. Value of F-18 FDG hybrid camera PET and MRI in early Takayasu aortitis. Eur Radiol 2003, 13:400-405.
47. Lee K.H., Cho A., Choi Y.J., et al. The role of (18) F-fluorodeoxyglucose-positron emission tomography in the assessment of disease activity in patients with Takayasu arteritis. Arthritis Rheum 2012, 64:866-875.
48. Fuchs M., Briel M., Daikeler T., et al. The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis. Eur J Nucl Med Mol Imaging 2012, 39:344-353.
49. Arnaud L., Haroche J., Malek Z., et al. Is (18)F-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in Takayasu arteritis?. Arthritis Rheum 2009, 60:1193-1200.
50. Kerr G.S., Hallahan C.W., Giordano J., et al. Takayasu arteritis. Ann Intern Med 1994, 120:919-929.
51. Aydin S.Z., Yilmaz N., Akar S., et al. Assessment of disease activity and progression in Takayasu's arteritis with Disease Extent Index-Takayasu. Rheumatology (Oxford) 2010, 49:1889-1893.
52. Blockmans D., Coudyzer W., Vanderschueren S., et al. Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology (Oxford) 2008, 47:1179-1184.
53. Vaglio A., Salvarani C., Buzio C. Retroperitoneal fibrosis. Lancet 2006, 367:241-251.
54. Salvarani C., Pipitone N., Versari A., et al. Positron emission tomography (PET): evaluation of chronic periaortitis. Arthritis Rheum 2005, 53:298-303.
55. Vaglio A., Pipitone N., Salvarani C. Chronic periaortitis: a large-vessel vasculitis?. Curr Opin Rheumatol 2011, 23:1-6.
56. Salvarani C., Brown R.D., Calamia K.T., et al. Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol 2007, 62:442-451.
57. Salvarani C., Brown R.D., Calamia K.T., et al. Primary CNS vasculitis with spinal cord involvement. Neurology 2008, 70:2394-2400.
58. Calabrese L.H., Mallek J.A. Primary angiitis of the central nervous system. Report of 8 new cases, review of the literature, and proposal for diagnostic criteria. Medicine (Baltimore) 1988, 67:20-39.
59. Birnbaum J., Hellmann D.B. Primary angiitis of the central nervous system. Arch Neurol 2009, 66:704-709.
60. Salvarani C., Brown R.D., Hunder G.G. Adult primary central nervous system vasculitis: an update. Curr Opin Rheumatol 2012, 24:46-52.
61. Zuccoli G., Pipitone N., Haldipur A., et al. Imaging findings in primary central nervous system vasculitis. Clin Exp Rheumatol 2011, 29:S104-S109.
62. Salvarani C., Brown R.D., Huston J., et al. Prominent perivascular enhancement in primary central nervous system vasculitis. Clin Exp Rheumatol 2008, 26:S111.
63. Gomes L.J. The role of imaging in the diagnosis of central nervous system vasculitis. Curr Allergy Asthma Rep 2010, 10:163-170.
64. Blockmans D., Bley T., Schmidt W. Imaging for large-vessel vasculitis. Curr Opin Rheumatol 2009, 21:19-28.
65. Pugliese F., Gaemperli O., Kinderlerer A.R., et al. Imaging of vascular inflammation with [11C]-PK11195 and positron emission tomography/computed tomography angiography. J Am Coll Cardiol 2010, 56:653-661.
66. Salvarani C., Brown R.D., Hunder G.G. Adult primary central nervous system vasculitis. Lancet 2012, 380:767-777.
67. Salvarani C., Brown R.D., Calamia K.T., et al. Angiography-negative primary central nervous system vasculitis: a syndrome involving small cerebral vessels. Medicine (Baltimore) 2008, 87:264-271.
68. Salvarani C., Brown R.D., Calamia K.T., et al. Primary central nervous system vasculitis with prominent leptomeningeal enhancement: a subset with a benign outcome. Arthritis Rheum 2008, 58:595-603.
69. Salvarani C., Brown R.D., Calamia K.T., et al. Rapidly progressive primary central nervous system vasculitis. Rheumatology (Oxford) 2011, 50:349-358.
70. Akman-Demir G., Bahar S., Coban O., et al. Cranial MRI in Behcet's disease: 134 examinations of 98 patients. Neuroradiology 2003, 45:851-859.
71. Serdaroglu P. Behcet's disease and the nervous system. J Neurol 1998, 245:197-205.
72. Noel N., Hutie M., Wechsler B., et al. Pseudotumoural presentation of neuro-Behcet's disease: case series and review of literature. Rheumatology (Oxford) 2012, 51:1216-1225.
73. Kocer N., Islak C., Siva A., et al. CNS involvement in neuro-Behcet syndrome: an MR study. AJNR Am J Neuroradiol 1999, 20:1015-1024.
74. Akman-Demir G., Serdaroglu P., Tasci B. Clinical patterns of neurological involvement in Behcet's disease: evaluation of 200 patients. The Neuro-Behcet Study Group. Brain 1999, 122(Pt 11):2171-2182.
75. Calamia K.T., Schirmer M., Melikoglu M. Major vessel involvement in Behcet's disease: an update. Curr Opin Rheumatol 2011, 23:24-31.
76. Duzgun N., Ates A., Aydintug O.T., et al. Characteristics of vascular involvement in Behcet's disease. Scand J Rheumatol 2006, 35:65-68.
77. Erkan F. Pulmonary involvement in Behcet disease. Curr Opin Pulm Med 1999, 5:314-318.
78. Newburger J.W., Takahashi M., Gerber M.A., et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004, 110:2747-2771.
79. Hiraishi S., Misawa H., Takeda N., et al. Transthoracic ultrasonic visualisation of coronary aneurysm, stenosis, and occlusion in Kawasaki disease. Heart 2000, 83:400-405.
80. Greil G.F., Stuber M., Botnar R.M., et al. Coronary magnetic resonance angiography in adolescents and young adults with Kawasaki disease. Circulation 2002, 105:908-911.
81. Stanson A.W., Friese J.L., Johnson C.M., et al. Polyarteritis nodosa: spectrum of angiographic findings. Radiographics 2001, 21:151-159.
82. Hekali P., Kajander H., Pajari R., et al. Diagnostic significance of angiographically observed visceral aneurysms with regard to polyarteritis nodosa. Acta Radiol 1991, 32:143-148.
83. Tarhan N.C., Coskun M., Kayahan E.M., et al. Regression of abdominal visceral aneurysms in polyarteritis nodosa: CT findings. AJR Am J Roentgenol 2003, 180:1617-1619.
84. Puechal X. Antineutrophil cytoplasmic antibody-associated vasculitides. Joint Bone Spine 2007, 74:427-435.
85. Lohrmann C., Uhl M., Kotter E., et al. Pulmonary manifestations of Wegener granulomatosis: CT findings in 57 patients and a review of the literature. Eur J Radiol 2005, 53:471-477.
86. Choi Y.H., Im J.G., Han B.K., et al. Thoracic manifestation of Churg-Strauss syndrome: radiologic and clinical findings. Chest 2000, 117:117-124.
87. Seo J.B., Im J.G., Chung J.W., et al. Pulmonary vasculitis: the spectrum of radiological findings. Br J Radiol 2000, 73:1224-1231.
88. Lauque D., Cadranel J., Lazor R., et al. Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Groupe d'Etudes et de Recherche sur les Maladies " Orphelines" Pulmonaires (GERM" O" P). Medicine (Baltimore) 2000, 79:222-233.
89. Gomez-Puerta J.A., Espinosa G., Morla R., et al. Interstitial lung disease as a presenting manifestation of microscopic polyangiitis successfully treated with mycophenolate mofetil. Clin Exp Rheumatol 2009, 27:166-167.
90. Ghinoi A., Zuccoli G., Pipitone N., et al. Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis involving the central nervous system: case report and review of the literature. Clin Exp Rheumatol 2010, 28:759-766.
91. Ghinoi A., Pipitone N., Cavazza A., et al. Wegener granulomatosis with spleen infarction: case report and review of the literature. Semin Arthritis Rheum 2008, 37:328-333.
92. Deniz K., Ozseker H.S., Balas S., et al. Intestinal involvement in Wegener's granulomatosis. J Gastrointestin Liver Dis 2007, 16:329-331.
93. Grayson P.C., Tomasson G., Cuthbertson D., et al. Association of vascular physical examination findings and arteriographic lesions in large vessel vasculitis. J Rheumatol 2012, 39:303-309.
94. Arnaud L., Haroche J., Amoura Z. The presence of atherosclerotic plaques in patients with Takayasu arteritis: comment on the article by Keenan et al. Arthritis Rheum 2010, 62:1558-1559.